Comprehensive search ChatGPT Online Scientific research tools
Sign in Sign Up

Science hub Mutual Aid community


[Elsevier] [Supplementary]DOI:https://doi.org/10.1016/S2468-1253(17)30246-7

SumetK Post time 3 day(s) ago | Show all posts |Read mode
Reward50points

[size=0.875]ARTICLES[color=var(--theme-font-color,#fff)][size=0.875]|[color=var(--theme-font-color,#fff)][size=0.875]VOLUME 2, ISSUE 10[color=var(--theme-font-color,#fff)][size=0.875][color=var(--theme-font-color,#fff)][size=0.875], [color=var(--theme-font-color,#fff)][size=0.875]P716-726, [color=var(--theme-font-color,#fff)][size=0.875]OCTOBER 2017[color=var(--theme-font-color,#fff)][color=var(--theme-font-color,#fff)]Download Full Issue









Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study[size=1.38]Published:August 14, 2017DOI:[color=var(--theme-font-color,#fff)]https://doi.org/10.1016/S2468-1253(17)30246-7



Needed Supplementary stuff of the articles. No need for manuscript texts only supplementary files needed.



Thanks












You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply1 Show all posts
Slavky Post time 3 day(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

SumetK Lv.2
Junior Member

  • post

  • reply

  • points

    0

Same Category

Latest Reply

Announcement

Enthusiastic users today

Return to the list